Medtronic PLC closed 8.69% short of its 52-week high of $96.25, which the company reached on March 10th.
Medtronic (NYSE:MDT) has appointed a former Dexcom leader as the new head of Americas for its Diabetes business unit.
Medtronic's stock has lost around a third of its value since late 2022. However, stock prices for longtime dividend growers ...
Medtronic (NYSE: MDT) stock was a fairly hot item as the trading week kicked off, with investors pushing the shares up by ...
Medtronic’s latest recall of the Pipeline Vantage 027 and 021 products is likely to result in revenue losses in the ...
4d
Zacks Investment Research on MSNMedtronic (MDT) Stock Moves -1.09%: What You Should KnowIn the latest market close, Medtronic (MDT) reached $87.89, with a -1.09% movement compared to the previous day. The stock exceeded the S&P 500, which registered a loss of 4.84% for the day. Meanwhile ...
Explore more
Medtronic plc (NYSE:MDT – Get Free Report) was the target of unusually large options trading on Friday. Traders acquired ...
Bearish flow noted in Medtronic (MDT) with 25,355 puts trading, or 7x expected. Most active are Jun-25 100 calls and Jan-26 85 puts, with total ...
Medtronic (NYSE:MDT) recently saw a substantial price movement, climbing 10% over the last quarter. This period was marked by ...
Hologic (Nasdaq: HOLX) announced that it appointed Wayde McMillan to its board of directors, effective April 4, 2025.
Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results